A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer

Cancer Statistics, 2002

Ahmedin Jemal, Anish Thomas, Thomas S. Murray et al. · CA A Cancer Journal for Clinicians · 2002 · 2.9K citations · Full text

Medicine, Demography, Oncology +17

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

William P. McGuire, William J. Hoskins, Mark F. Brady et al. · New England Journal of Medicine · 1996 · 2.9K citations · Full text

Medicine, Gynecology, Oncology +16

Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53

Suzanne J. Baker, Sanford D. Markowitz, Eric R. Fearon et al. · Science · 1990 · 1.8K citations

Medicine, Genetics, Oncology +17

Development of adenovirus vectors for the expression of heterologous genes.

Kathleen L. Berkner · PubMed · 1990 · 385 citations

Life Sciences, Molecular Biology, Molecular Genetics +13

p53 gene mutations and protein accumulation in human ovarian cancer.

Jolanta Kupryjańczyk, Ann D. Thor, Roberta L. Beauchamp et al. · Proceedings of the National Academy of Sciences · 1993 · 299 citations · Full text

Medicine, Genetics, Oncology +17